• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重要的性腺功能减退症和睾酮替代疗法在当前的泌尿科实践:一个审查。

Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.

机构信息

Department of Urology, Tulane University, Health Sciences Center, 1430 Tulane Avenue, SL-42, New Orleans, LA 70112, USA.

出版信息

Int Urol Nephrol. 2012 Feb;44(1):61-70. doi: 10.1007/s11255-010-9879-4. Epub 2010 Dec 9.

DOI:10.1007/s11255-010-9879-4
PMID:21152980
Abstract

Evaluation of potential candidates for testosterone replacement therapy (TRT) includes a complete medical history, physical examination, and hormonal screening. The choice of testosterone assay is important in clinical decision making. TRT should, in theory, approximate natural endogenous production of the hormone. There is no apparent association between TRT and the development of prostate cancer. The administration of exogenous testosterone is not a means of reversing the aging process in men with normal testosterone levels, but it may offer considerable benefit for those with hypogonadism.

摘要

评估潜在的睾酮替代疗法 (TRT) 候选人包括完整的病史、体格检查和激素筛查。睾酮检测方法的选择对临床决策很重要。TRT 理论上应接近激素的内源性自然产生。TRT 与前列腺癌的发展之间似乎没有明显关联。外源性睾酮的给药并不是逆转正常睾酮水平男性衰老过程的手段,但它可能对性腺功能减退症患者有很大益处。

相似文献

1
Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.重要的性腺功能减退症和睾酮替代疗法在当前的泌尿科实践:一个审查。
Int Urol Nephrol. 2012 Feb;44(1):61-70. doi: 10.1007/s11255-010-9879-4. Epub 2010 Dec 9.
2
Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.性腺功能减退与睾酮治疗:与心血管风险的关联
Am J Mens Health. 2015 Jul;9(4):340-4. doi: 10.1177/1557988314540933. Epub 2014 Jun 26.
3
Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.HIV/AIDS 男性性腺功能减退症的最佳诊断方法和阈值:两种经皮睾酮替代治疗凝胶的比较。
Postgrad Med. 2013 Mar;125(2):30-9. doi: 10.3810/pgm.2013.03.2639.
4
Testosterone Therapy: What We Have Learned From Trials.睾酮治疗:从试验中我们学到了什么。
J Sex Med. 2020 Mar;17(3):447-460. doi: 10.1016/j.jsxm.2019.11.270. Epub 2020 Jan 9.
5
Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.睾酮替代疗法对2型糖尿病性腺功能减退男性性功能和血糖控制的影响。
Int J Impot Res. 2019 Jan;31(1):25-30. doi: 10.1038/s41443-018-0065-z. Epub 2018 Aug 22.
6
Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.睾酮替代疗法治疗迟发性性腺功能减退症:韩国的当前趋势。
Asian J Androl. 2011 Jul;13(4):563-8. doi: 10.1038/aja.2010.124. Epub 2011 May 16.
7
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.近距离放射治疗早期前列腺癌后性腺功能减退的睾酮替代治疗。
Cancer. 2007 Feb 1;109(3):536-41. doi: 10.1002/cncr.22438.
8
Investigating the basis of sexual dysfunction during late-onset hypogonadism.探究迟发性性腺功能减退期间性功能障碍的基础。
F1000Res. 2019 Mar 25;8. doi: 10.12688/f1000research.16561.1. eCollection 2019.
9
Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.雄激素受体基因CAG重复多态性独立影响术后低促性腺激素性性腺功能减退患者睾酮替代治疗后男性性功能的恢复。
J Sex Med. 2014 May;11(5):1302-8. doi: 10.1111/jsm.12493. Epub 2014 Mar 4.
10
Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.患有勃起功能障碍男性的性腺功能减退:需关注的要点及治疗时机
Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z.

引用本文的文献

1
Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects.外源性睾酮替代疗法与提高内源性睾酮水平:现状与未来展望。
F S Rev. 2021 Jan;2(1):32-42. doi: 10.1016/j.xfnr.2020.11.001. Epub 2020 Nov 17.
2
Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance.在接受主动监测的前列腺癌患者队列中,与临床参数相关的睾酮谱水平随时间的变化。
World J Urol. 2018 Aug;36(8):1209-1217. doi: 10.1007/s00345-018-2270-2. Epub 2018 Mar 20.
3
Testosterone deficiency in adults and corresponding treatment patterns across the globe.

本文引用的文献

1
Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy.绝经后女性与接受双侧卵巢切除术女性的同位素稀释-液相色谱-串联质谱法测定的血清睾酮水平。
Ann Clin Biochem. 2010 May;47(Pt 3):248-52. doi: 10.1258/acb.2010.009171. Epub 2010 Apr 20.
2
Standardization of testosterone measurements in humans.人类睾酮测量的标准化。
J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):513-9. doi: 10.1016/j.jsbmb.2010.03.032. Epub 2010 Mar 17.
3
Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study.
全球成人睾酮缺乏症及相应治疗模式
Transl Androl Urol. 2017 Apr;6(2):183-191. doi: 10.21037/tau.2016.11.16.
4
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.治疗和未治疗前列腺癌患者的睾酮治疗:对肿瘤学结局的影响。
J Urol. 2016 Oct;196(4):1082-9. doi: 10.1016/j.juro.2016.04.069. Epub 2016 Apr 27.
5
Assessment of an ethanolic seed extract of Picralima nitida ([Stapf] Th. and H. Durand) on reproductive hormones and its safety for use.对 Picralima nitida([Stapf] Th. 和 H. Durand)乙醇种子提取物对生殖激素的影响及其使用安全性的评估。
J Intercult Ethnopharmacol. 2015 Oct-Dec;4(4):293-301. doi: 10.5455/jice.20151030085004. Epub 2015 Nov 2.
6
Update on Testosterone Replacement Therapy in Hypogonadal Men.性腺功能减退男性睾酮替代疗法的最新进展
Curr Urol Rep. 2015 Aug;16(8):57. doi: 10.1007/s11934-015-0523-9.
7
Quality of Life and Sexual Health in the Aging of PCa Survivors.前列腺癌幸存者老龄化过程中的生活质量与性健康
Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.
8
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.前列腺癌根治术后患者的睾酮替代治疗。
J Urol. 2013 Aug;190(2):639-44. doi: 10.1016/j.juro.2013.02.002. Epub 2013 Feb 8.
筛查勃起功能障碍患者代谢综合征和睾酮缺乏症:来自英国首个前瞻性研究的结果。
BJU Int. 2010 Sep;106(5):688-90. doi: 10.1111/j.1464-410X.2009.09145.x.
4
Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometry.采用超滤法结合液质联用技术直接测定血清游离睾酮。
Clin Biochem. 2010 Mar;43(4-5):490-6. doi: 10.1016/j.clinbiochem.2009.12.005. Epub 2009 Dec 21.
5
Age-related morphological changes in smooth muscle and collagen content in human corpus cavernosum.人类海绵体平滑肌和胶原含量的年龄相关性形态变化。
J Sex Med. 2010 Aug;7(8):2723-8. doi: 10.1111/j.1743-6109.2009.01508.x. Epub 2009 Sep 29.
6
Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods.采用质谱法进行血清总睾酮[校正后]测量的实验室间比对研究。
Steroids. 2009 Jun;74(6):498-503. doi: 10.1016/j.steroids.2009.01.004. Epub 2009 Jan 30.
7
The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction.睾酮水平随年龄的下降与性功能障碍患者的不同特定症状和体征相关。
Int J Androl. 2009 Dec;32(6):720-8. doi: 10.1111/j.1365-2605.2009.00952.x. Epub 2009 Feb 10.
8
Predictive accuracy and sources of variability in calculated free testosterone estimates.计算游离睾酮估计值的预测准确性和变异性来源。
Ann Clin Biochem. 2009 Mar;46(Pt 2):137-43. doi: 10.1258/acb.2008.008171.
9
Screening for erectile dysfunction in men with lifelong premature ejaculation--Is the Sexual Health Inventory for Men (SHIM) reliable?对患有终身性早泄的男性进行勃起功能障碍筛查——男性性健康量表(SHIM)是否可靠?
J Sex Med. 2009 Feb;6(2):567-73. doi: 10.1111/j.1743-6109.2008.01092.x.
10
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.男性迟发性性腺功能减退的调查、治疗及监测:国际男性不育学会(ISA)、国际男性学学会(ISSAM)、欧洲泌尿外科学会(EAU)、欧洲男科学会(EAA)及美国男科学会(ASA)的建议
Eur J Endocrinol. 2008 Nov;159(5):507-14. doi: 10.1530/EJE-08-0601.